Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
Gabriella Captur(The Royal Free Hospital), Wendy Heywood(Great Ormond Street Hospital), Daniel M. Altmann(Imperial College London), Rosemary J. Boyton(Imperial College London), Mahdad Noursadeghi(University College London), Constantin‐Cristian Topriceanu(Barts Health NHS Trust), Tim Brooks, Thomas A. Treibel(National Institutes of Health), Nina Patel(Great Ormond Street Hospital), Kevin Mills(Great Ormond Street Hospital), Áine McKnight(Queen Mary University of London), Charlotte Manisty(National Institutes of Health), Marianna Fontana(Johnson & Johnson (United States)), George Joy(St Bartholomew's Hospital), Ivan Doykov(Great Ormond Street Hospital), Leo Swadling(The London College), Benjamin O’Brien(St Bartholomew's Hospital), Tomas Baldwin(Great Ormond Street Hospital), Katia Menacho(St Bartholomew's Hospital), Jenny Hällqvist(Great Ormond Street Hospital), Mala K. Maini(University College London), Justyna Śpiewak(Great Ormond Street Hospital), Corrina Pade(Queen Mary University of London), James Moon(Virginia Mason Medical Center), Matt Hamblin(St Bartholomew's Hospital), Joseph M. Gibbons(Queen Mary University of London)
Cited by 70
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
|Journal of Cardiovascular Magnetic Resonance|2013|1.1k
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
|Circulation|2005|978
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767